Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VS-101 + CRT in Head and Neck Cancer
NCT06959082Phase 2Recruiting
- Sponsor
- VSPharmTech
- Start
- Jun 2025
- Primary completion
- Dec 2027
- Modality
- Recombinant Proteins and Enzymes, PEGylated Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of VS-101 in head and neck squamous cell carcinoma (HNSCC), sponsored by VSPharmTech. Started Jun 2025; status: recruiting.
02
Drugs
VS-101
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT06959082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06959082.